UBS Group
PAVMW

UBS Group’s PAVmed Inc. Warrant PAVMW Stock Holding History

UBS Group’s Portfolio PAVMW Stock Details PAVMW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,198
Closed – – 11565
2021
Q4 		$0 Buy
2,198
+941
+75% +$1.14K ﹤0.01% 11229
2021
Q3 		$5K Sell
1,257
-309
-20% -$847 ﹤0.01% 8608
2021
Q2 		$3K Buy
1,566
+264
+20% +$459 ﹤0.01% 8903
2021
Q1 		$2K Buy
1,302
+631
+94% +$611 ﹤0.01% 8705
2020
Q4 		$0 Sell
671
-29
-4% -$22 ﹤0.01% 8983
2020
Q3 		$1K Hold
700
– – ﹤0.01% 7894
2020
Q2 		$1K Sell
700
-818
-54% -$895 ﹤0.01% 7854
2020
Q1 		$1K Buy
+1,518
New +$1.23K ﹤0.01% 7863
2018
Q2 		– Sell
-800
Closed – – 8371
2018
Q1 		$0 Sell
800
-3,149
-80% -$1.48K ﹤0.01% 8319
2017
Q4 		$2K Buy
+3,949
New +$4.51K ﹤0.01% 7653
2017
Q3 		– Sell
-30
Closed – – 8114
2017
Q2 		$0 Hold
30
– – ﹤0.01% 8121
2017
Q1 		$0 Hold
30
– – ﹤0.01% 8126
2016
Q4 		$0 Sell
30
-30
-50% -$187 ﹤0.01% 8151
2016
Q3 		$0 Buy
+60
New +$444 ﹤0.01% 8061

UBS Group's PAVMW Position: Q1 2022 in Review

UBS Group sold out of PAVmed Inc. Warrant (PAVMW) in Q1 2022, closing a stake of 2,198 shares.

UBS Group first reported a position in PAVMW in Q3 2016 and held it in 14 quarters. The position peaked at $5K in Q3 2021. 0 funds tracked by Wall St. Rank hold PAVMW as of Q1 2022.

  • UBS Group reported no remaining PAVmed Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • UBS Group sold 2,198 PAVmed Inc. Warrant shares in Q1 2022.
  • UBS Group first reported a position in PAVmed Inc. Warrant in Q3 2016 and held it in 14 quarters.
  • UBS Group's PAVmed Inc. Warrant position peaked at $5K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held PAVmed Inc. Warrant as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.